Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week

Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week

Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of May 18th – 24th, 2020.

Without further ado, let’s get started.

Yahoo Finance readers, please click here to view full article.

10. FULLY UPDATED – These 2 Companies Could Be Turning LSD, Magic Mushrooms, Ketamine and MDMA into the Next Blockbuster Drugs

Investors Who Missed the Last Bull Market in Weed Stocks or Got in Too Late Should Start Researching the “Shroom Boom” Immediately

Early cannabis investors and business minds are positioning themselves in the world of Psychedelic Medicine as the flow of smart money hits the market. Canopy Growth CGC founder Bruce Linton and Billionaire “Mr. Wonderful” Kevin O’Leary from Shark Tank, are going all-in on what they think is a much bigger opportunity than the Cannabis Boom.

Backed by popular demand, we have fully updated this article, which we originally published on 03/28/2020 to reflect the many significant developments that have occurred in the Psychedelics space over the past two months. Within a matter of hours, after the original version was released, it quickly went viral becoming our most viewed article off all-time within two days. Because the article is still experiencing very high traffic, we felt it was necessary to fully update it so our readers could have access to the most up to date information possible. In our opinion, the newly updated version is even better than the original so we highly suggest giving it a read if you’re interested in learning about Psychedelic Medicine and the top investment opportunities in the sector.


9. Cannabis Boom 2.0: Here’s Why ‘Some Pot Stocks’ Are Soaring Like We Haven’t Seen Since 2018

While the 1.5 Year Cannabis Correction Tested the Nerve of Investors, it Also Exposed the Weak Companies and Similar to the Dot-Com Bubble, Separated the Winners from the Losers

Cannabis Stocks are back in vogue following a lengthy bear market, which began at the same time Canada legalized adult-use marijuana in October 2018. With many of the losers of the ‘Canadian Cannabis Bubble’ now gone or close to it, the field has been narrowed down creating a more attractive environment for the winners to flourish and their share prices to continue rising. Check out our full list of winners and losers from the Cannabis Boom 1.0. This list of Pot Stocks will help investors focus their attention on the companies with the highest chance to succeed during the new Cannabis Boom 2.0, which is taking place in the world’s largest marijuana market.


8. Psychedelic Stocks May Be One of the Most Undervalued Opportunities, Here’s How to Play the Thriving New Sector

Surging Investor Demand Continues to Be Concentrated into a Limited Number of Psychedelic Stocks

As the Psychedelics industry continues to blossom, the current circumstances have created a situation for investors that has enormous potential upside. As more companies attempt to enter the burgeoning space, investors would be wise to focus their investment dollars on the proven sector leaders such as Champignon Brands SHRMF and MindMed MMEDF.


7. These 2 Pot Stocks Have the Most Cash to Weather the Downturn

Canopy and Cronos Have More Cash on Hand Than Most Other Cannabis Companies, But Are They Buys?

Many marijuana companies have little by way of cash on hand to fund their operations, and many of them will have to take on additional debt — or find ways to reduce their expenses — to survive. Fortunately, some pot companies have a boatload of cash on their balance sheets. Let’s look at two of these companies: Canopy Growth CGC and Cronos Group CRON.


6. It’s Time to Revisit Psychedelic Drugs That Are Proving Useful for Health

Psychedelic Drugs May Be Banned Around the World at the Moment, But That May Not Be the Case for Much Longer

As we learn more about how useful such treatments can be, it’s opening a wide range of opportunities for the proven industry leaders like Champignon Brands SHRMF and Mind medicine MindMed MMEDF. We’re now seeing a wide range of other companies like The Yield Growth Corp. BOSS, NewLeaf Brands NLB, Pharmadrug Inc. BUZZ, Numinus Wellness Inc. NUMI enter the potential lucrative psychedelics space looking for a piece of the action.


5. Cronos Group Can “Dominate” the American CBD Market: Raymond James

Despite Ongoing Murkiness in the U.S. CBD Market Stocks Like Cronos Should Get a Boost From Aurora Cannabis’ Recent Breakthrough CBD Deal

That’s according to analyst Rahul Sarugaser from Raymond James who reviewed the current state of affairs in a recent update to clients where he reiterated his “Market Perform 3” rating for Cronos Group CRONAurora Cannabis ACB made a splash this week with the purchase of U.S. CBD company Reliva.


4. Champignon Brands Sponsors Group Focused on Medical Psilocybin Access Aimed at Palliative Cancer Patients

The TheraPsil Coalition Will Start in 2020 Seeking Legal Access to Psilocybin for British Columbians With a Palliative Diagnosis and Psychological Distress

Champignon Brands SHRM announced they have sponsored TheraPsil, a BC-based non-profit coalition of healthcare professionals, policy-makers and community leaders seeking legal access to psilocybin for British Columbians with a palliative diagnosis and psychological distress


3. Trulieve Hits Milestone, Opens 50th — And Largest — U.S. Dispensary

According to Trulieve, the Newly Opened Dispensary is Located in Daytona Beach, Bringing the Company’s Total Stores in Florida to 48

Trulieve TCNNF has cut the ribbon on its latest store, marking its 50th retail location. Located at 812 West International Speedway Boulevard, Trulieve’s newest location is one of the company’s largest. It spans about 6,000 square feet, and includes about 1,500 square feet of showroom space and 14 selling points.


2. Aurora Cannabis to Enter U.S. Market with $40 Million of Acquisition of CBD Brand Reliva

Aurora Says it’s Entering the U.S. Market by Acquiring Hemp-Based Cannabidiol Company Reliva

Aurora Cannabis ACB will acquire all of the issued and outstanding membership interests of Reliva, while Reliva members will receive roughly US$40 million in Aurora’s common shares.


1. 3 Stocks to Buy for Psychedelic Profits

Buy These Psychedelic Stocks to Get in on an Increasingly Popular Trend in Healthcare

Psychedelic research is clearly gaining traction, and investors should take note. Here are three top Psychedelic Stocks to buy now:

  1. Champignon Brands SHRMF 
  2. MindMed MMEDF
  3. Revive Therapeutics RVVTF


Photo by Roberto Valdivia on Unsplash

Posted In: cannabis industryThe Cannabis InvestorTrulieveCannabisNewsPenny StocksMarketsGeneral


Meet the biggest cannabis industry players and make deals that will push the industry forward.

Featuring live company presentations, insider panels, and unmatched access to networking, the Benzinga Cannabis Capital Conference is where cannabis executives and entrepreneurs meet.

Join us September 13-14, 2022 at The Palmer House in Chicago, IL.